Stage 4 neuroblastoma: Sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment

R. Luksch, M. Podda, L. Gandola, D. Polastri, L. Piva, R. Castellani, P. Collini, M. Massimino, G. Cefalo, M. Terenziani, A. Ferrari, M. Casanova, F. Spreafico, C. Meazza, F. Bozzi, A. Marchianò, F. Ravagnani, F. Fossati-Bellani

Research output: Contribution to journalArticlepeer-review

Abstract

The aim of the present study was to evaluate the effectiveness of two consecutive nonrandomised treatment programs applied between 1989 and 1999 at the Istituto Nazionale Tumori of Milan in an unselected cohort of 59 children over the age of one with stage 4 neuroblastoma. Both treatment programs consisted of two phases, the induction of the remission phase and the consolidation phase. The induction of the remission phase consisted of intensive chemotherapy, and remained the same throughout the study period. The consolidation phase consisted of sequential hemi-body irradiation (HBI) (10Gy per session, 6 weeks apart) in the first period (1988-June 1994) and sequential high-dose cyclophosphamide, etoposide, mitoxantrone + L-PAM and autologous haemopoietic stem cell transplantation in the second (July 1994-1999). Intention-to-treat analysis revealed a significantly better outcome for patients treated with the second program, the 5-year event-free survival probability being 0.12 for program 1 and 0.31 for program 2 (P = 0.03). This finding led us to conclude that sequential HBI is useless as consolidation treatment. The high-dose chemotherapy adopted in the second program enabled a proportion of patients to obtain long-term survival but, since the clinical results remain unsatisfactory, new treatment strategies are warranted.

Original languageEnglish
Pages (from-to)1984-1988
Number of pages5
JournalBritish Journal of Cancer
Volume92
Issue number11
DOIs
Publication statusPublished - Jun 6 2005

Keywords

  • Autologous stem cell transplantation
  • Neuroblastoma
  • Sequential hemi-body irradiation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Stage 4 neuroblastoma: Sequential hemi-body irradiation or high-dose chemotherapy plus autologous haemopoietic stem cell transplantation to consolidate primary treatment'. Together they form a unique fingerprint.

Cite this